Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury

Clinical trial NCT06825143 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06825143
Sponsor: Gary Van Guilder
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Metabolic Syndrome Vascular Injury Ischemic Preconditioning Endothelial Function (reactive Hyperemia)Endothelial Dysfunction

Start date: 2026-10-01
Primary completion: 2029-09-30
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.